These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 29035090)
1. Early Respiratory Bacterial Detection and Antistaphylococcal Antibiotic Prophylaxis in Young Children with Cystic Fibrosis. Hurley MN; Fogarty A; McKeever TM; Goss CH; Rosenfeld M; Smyth AR Ann Am Thorac Soc; 2018 Jan; 15(1):42-48. PubMed ID: 29035090 [TBL] [Abstract][Full Text] [Related]
2. Prophylactic anti-staphylococcal antibiotics for cystic fibrosis. Rosenfeld M; Rayner O; Smyth AR Cochrane Database Syst Rev; 2020 Sep; 9(9):CD001912. PubMed ID: 32997797 [TBL] [Abstract][Full Text] [Related]
5. Effect of continuous antistaphylococcal therapy on the rate of P. aeruginosa acquisition in patients with cystic fibrosis. Ratjen F; Comes G; Paul K; Posselt HG; Wagner TO; Harms K; Pediatr Pulmonol; 2001 Jan; 31(1):13-6. PubMed ID: 11180669 [TBL] [Abstract][Full Text] [Related]
7. Palivizumab prophylaxis in infants with cystic fibrosis does not delay first isolation of Pseudomonas aeruginosa or Staphylococcus aureus. Buchs C; Dalphin ML; Sanchez S; Perceval M; Coutier L; Mainguy C; Kassaï-Koupaï B; Reix P Eur J Pediatr; 2017 Jul; 176(7):891-897. PubMed ID: 28508992 [TBL] [Abstract][Full Text] [Related]
8. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis. Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M BMC Infect Dis; 2017 Jun; 17(1):411. PubMed ID: 28599639 [TBL] [Abstract][Full Text] [Related]
9. Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis. Psoter KJ; De Roos AJ; Wakefield J; Mayer J; Rosenfeld M Clin Microbiol Infect; 2013 Nov; 19(11):E483-9. PubMed ID: 23795938 [TBL] [Abstract][Full Text] [Related]
10. Multicenter Observational Study on Factors and Outcomes Associated with Various Methicillin-Resistant Staphylococcus aureus Types in Children with Cystic Fibrosis. Muhlebach MS; Heltshe SL; Popowitch EB; Miller MB; Thompson V; Kloster M; Ferkol T; Hoover WC; Schechter MS; Saiman L; Ann Am Thorac Soc; 2015 Jun; 12(6):864-71. PubMed ID: 25745825 [TBL] [Abstract][Full Text] [Related]
11. Sustained Coinfections with Fischer AJ; Singh SB; LaMarche MM; Maakestad LJ; Kienenberger ZE; Peña TA; Stoltz DA; Limoli DH Am J Respir Crit Care Med; 2021 Feb; 203(3):328-338. PubMed ID: 32750253 [No Abstract] [Full Text] [Related]
12. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. Langton Hewer SC; Smyth AR Cochrane Database Syst Rev; 2014 Nov; (11):CD004197. PubMed ID: 25383937 [TBL] [Abstract][Full Text] [Related]
13. Prophylactic antibiotics in cystic fibrosis: a conviction without evidence? Smyth A Pediatr Pulmonol; 2005 Dec; 40(6):471-6. PubMed ID: 16200640 [TBL] [Abstract][Full Text] [Related]
15. Ivacaftor Is Associated with Reduced Lung Infection by Key Cystic Fibrosis Pathogens. A Cohort Study Using National Registry Data. Frost FJ; Nazareth DS; Charman SC; Winstanley C; Walshaw MJ Ann Am Thorac Soc; 2019 Nov; 16(11):1375-1382. PubMed ID: 31319678 [No Abstract] [Full Text] [Related]
16. Staphylococcus aureus in the airways of cystic fibrosis patients - A retrospective long-term study. Schwerdt M; Neumann C; Schwartbeck B; Kampmeier S; Herzog S; Görlich D; Dübbers A; Große-Onnebrink J; Kessler C; Küster P; Schültingkemper H; Treffon J; Peters G; Kahl BC Int J Med Microbiol; 2018 Aug; 308(6):631-639. PubMed ID: 29501453 [TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis. Treggiari MM; Retsch-Bogart G; Mayer-Hamblett N; Khan U; Kulich M; Kronmal R; Williams J; Hiatt P; Gibson RL; Spencer T; Orenstein D; Chatfield BA; Froh DK; Burns JL; Rosenfeld M; Ramsey BW; Arch Pediatr Adolesc Med; 2011 Sep; 165(9):847-56. PubMed ID: 21893650 [TBL] [Abstract][Full Text] [Related]